{"schema_version":"secwatch.filing_event.v1","accession":"0001217234-25-000045","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.515707+00:00","generated_at":"2026-05-17T18:56:57.737948+00:00","sec_items":["2.02","9.01","5.02","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CareDx Q2 adjusted revenue up 14% YoY to $90.5M; narrows FY guidance; appoints new CFO","bullets":["Q2 adjusted revenue $90.5M (+14% YoY); GAAP revenue $86.7M (-6% YoY) due to $3.8M aged receivable write-off.","Testing services volume ~49,500 (+13% YoY); AlloSure Kidney volume up ~20% YoY.","GAAP net loss $8.6M ($0.16/sh) vs $4.6M loss; non-GAAP net income $5.6M ($0.10/sh) vs $13.6M.","Adjusted EBITDA $9.1M (excl. $3.8M write-off) vs prior year loss $0.3M.","CFO change: Nathan Smith appointed, effective Aug 7, 2025; Abhishek Jain retired; Smith receives $400K salary, RSUs, PSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001217234-25-000045","json":"https://secwatch.observer/filing/0001217234-25-000045.json","markdown":"https://secwatch.observer/filing/0001217234-25-000045.md","text":"https://secwatch.observer/filing/0001217234-25-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/0001217234-25-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000045/cdna-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:56:57.737948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}